We're on episode 5 of the GxPodcast already!

In this episode, we're joined by a prominent figure in the pharmaceutical and biotechnology industries for nearly three decades, focusing on quality, compliance, and the manufacturing of advanced therapeutic products.

Throughout his journey, Carlos Yuraszeck has been instrumental in developing effective Quality Systems aimed at enabling Compliance by Design across the GxP spectrum.

Most recently, as the Head of GMP Manufacturing at the Astellas Institute of Regenerative Medicine, Carlos was responsible for various functions, including MS&T, Cell Manufacturing, and Engineering.

At Celgene, Carlos played a pivotal role in launching a groundbreaking treatment for Multiple Myeloma, contributing to the company's evolution into one of the most successful biotech companies. His expertise extends beyond product development to include building and running manufacturing facilities, understanding regulatory requirements, and collaborating with overseeing agencies. This unique combination of skills allows him to guide therapies from concept to patient treatment.

Prior to Celgene, Carlos held positions at Pfizer, Pharmacia, and Merck, where he gained experience in Quality Assurance, Quality Control, Validation, and Corporate Compliance. #GXPodcast